Francesca Di Stefano

Phase I Clinical and Pharmacokinetic Study of Bcl-2 Antisense Oligonucleotide Therapy in Patients With Non-Hodgkin’s Lymphoma

Justin S. Waters, Andrew Webb, David Cunningham et al. · Journal of Clinical Oncology · 2000 · 455 citations

Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941

Florence I. Raynaud, Suzanne A. Eccles, Sonal Patel et al. · Molecular Cancer Therapeutics · 2009 · 270 citations · Full text

Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperone

Paul A. Clarke, Isabelle Hostein, Udai Banerji et al. · Oncogene · 2000 · 199 citations

Signal Transduction, Medicine, Colorectal Cancer +8

Ultrastructural localization of BHRF1: an Epstein-Barr virus gene product which has homology with bcl-2.

Tamas Hickish, David Robertson, Paul A. Clarke et al. · PubMed · 1994 · 71 citations

Ultrastructural Localization, Mitophagy, Cell Regulation +13

Preparation and evaluation of trisubstituted pyrimidines as phosphatidylinositol 3-kinase inhibitors. 3-Hydroxyphenol analogues and bioisosteric replacements

Jonathan M. Large, Jane E. Torr, Florence I. Raynaud et al. · Bioorganic & Medicinal Chemistry · 2010 · 21 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Pharmaceutical Science +13